Indaptus Therapeutics, Inc. - Common Stock (INDP)
0.4504
+0.00 (0.00%)
NASDAQ · Last Trade: Jun 25th, 6:30 AM EDT
Detailed Quote
Previous Close | 0.4504 |
---|---|
Open | - |
Bid | 0.4332 |
Ask | 0.4504 |
Day's Range | N/A - N/A |
52 Week Range | 0.2701 - 2.421 |
Volume | 17,622 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 19,533,996 |
Chart
About Indaptus Therapeutics, Inc. - Common Stock (INDP)
Indaptus Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with serious and life-threatening diseases. The company specializes in leveraging advanced technologies to create novel treatments that aim to harness the body's immune system and improve therapeutic outcomes. By advancing its pipeline of drug candidates, Indaptus Therapeutics seeks to address unmet medical needs and provide new hope for patients suffering from various forms of cancer and other challenging conditions. Read More
News & Press Releases
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:INDP),(NYSE:CATX),(NASDAQ:SLS),(NASDAQ:AUTL EQNX::TICKER_END
Via FinancialNewsMedia · June 24, 2025
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · June 24, 2025
Via Benzinga · June 24, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · June 23, 2025
Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · June 23, 2025
Via Benzinga · June 23, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.
Via Chartmill · June 23, 2025
Discover the top movers in Monday's pre-market session and stay informed about market dynamics.
Via Chartmill · June 23, 2025
Via Benzinga · June 23, 2025
Via Benzinga · June 23, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.
Via Chartmill · May 30, 2025

Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · May 30, 2025

The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · May 30, 2025

Via Benzinga · May 29, 2025

After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · May 29, 2025

Via Benzinga · May 28, 2025
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill · March 25, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the stocks with an unusual volume in today's session.
Via Chartmill · March 19, 2025
Indaptus advanced its Decoy20 trial to test a combination with tislelizumab, aiming to enhance checkpoint inhibitor effectiveness in cancer treatment.
Via Benzinga · March 18, 2025

Via Benzinga · January 13, 2025

Via Benzinga · September 27, 2024

INDP stock results show that Indaptus Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 12, 2024